These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3284115)

  • 21. Cyclosporine regulation of blood transfusion sensitizing and enhancing potential in rabbit skin allograft recipients.
    Smit WJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1105-9. PubMed ID: 3291220
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine in transplantation.
    Harwood CH; Cook CV
    Heart Lung; 1985 Nov; 14(6):529-40. PubMed ID: 3902726
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of low-dose cyclosporine A and multiple blood transfusions on heart graft survival in highly sensitized rats.
    de Bruin RW; Bouwman E; Heineman E; Marquet RL; Jeekel J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1094-6. PubMed ID: 3291217
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine in transplantation of the liver in the dog.
    Williams JW; Peters TG; Haggitt R; Van Voorst S
    Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients.
    Lindholm A; Lundgren G; Fehrman I; Weibull H; Brynger H; Frödin L; Flatmark A
    Transplant Proc; 1988 Jun; 20(3):444-6. PubMed ID: 3289181
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin.
    Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR
    J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    Transplantation; 1986 Nov; 42(5):466-72. PubMed ID: 3538531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog.
    Homan WP; French ME; Millard PR; Morris PJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):397-401. PubMed ID: 7022860
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous cyclosporine for heart transplantation.
    Bolman RM; Cance CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of skin allograft survival in mice following administration of ALLOTRAP.
    Buelow R; Veyron P; Clayberger C; Pouletty P; Touraine JL
    Transplantation; 1995 Feb; 59(4):455-60. PubMed ID: 7878745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
    Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contrary action of khingamin on the rejection of a skin allograft and on the level of antibody-producing cells in mice].
    Gamburg LIu; Cheredeev AN
    Biull Eksp Biol Med; 1987 Jun; 103(6):727-30. PubMed ID: 3297194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
    Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of cyclosporine A in the treatment of acute renal allograft rejection.
    Gascon M; Donnelly S; Lowry RP
    Transplant Proc; 1987 Aug; 19(4):3481-5. PubMed ID: 3303519
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.